Short Interest in Amsurg Corp. (AMSG) Increases By 21.9%
Amsurg Corp. (NASDAQ:AMSG) saw a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 10,675,274 shares, an increase of 21.9% from the August 31st total of 8,757,733 shares. Currently, 19.9% of the shares of the stock are sold short. Based on an average daily volume of 1,289,022 shares, the days-to-cover ratio is currently 8.3 days.
Shares of Amsurg Corp. (NASDAQ:AMSG) opened at 66.58 on Thursday. Amsurg Corp. has a 52 week low of $58.37 and a 52 week high of $87.29. The firm’s 50-day moving average is $65.46 and its 200-day moving average is $73.54. The stock has a market capitalization of $3.58 billion, a price-to-earnings ratio of 19.76 and a beta of 0.65.
Amsurg Corp. (NASDAQ:AMSG) last posted its earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.02. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. Amsurg Corp.’s revenue was up 21.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.97 earnings per share. On average, equities research analysts anticipate that Amsurg Corp. will post $4.33 EPS for the current fiscal year.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $64.36, for a total transaction of $482,700.00. Following the sale, the insider now owns 105,007 shares of the company’s stock, valued at approximately $6,758,250.52. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 2.30% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Emerald Acquisition Ltd. purchased a new stake in Amsurg Corp. during the second quarter valued at $106,000. Smith Asset Management Group LP raised its stake in Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares during the period. Invictus RG raised its stake in Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the period. Checchi Capital Advisers LLC bought a new stake in Amsurg Corp. during the second quarter worth approximately $157,000. Finally, Advisor Group Inc. bought a new stake in Amsurg Corp. during the second quarter worth approximately $202,000. 98.42% of the stock is currently owned by institutional investors.
AMSG has been the topic of several recent research reports. Jefferies Group reaffirmed a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Robert W. Baird reiterated a “buy” rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Zacks Investment Research upgraded Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price target on the stock in a report on Monday, July 11th. Citigroup Inc. started coverage on Amsurg Corp. in a report on Monday. They set a “buy” rating and a $79.00 price target on the stock. Finally, Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Amsurg Corp. currently has a consensus rating of “Buy” and an average target price of $92.55.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.